China Medical Systems

Executive Summary

China Medical Systems is a commercial-stage biopharmaceutical company based in Shenzhen, China, specializing in dermatology and ophthalmology. With over 1,000 employees and a strong commercial footprint in China, the company focuses on in-licensing late-stage candidates while building its own R&D capabilities. Its portfolio of small molecule drugs addresses significant unmet needs in the Chinese market, leveraging the country's growing demand for innovative therapies. The company's established sales infrastructure and regulatory expertise position it well to capture market share in these therapeutic areas.

Upcoming Catalysts (preview)

• H2 2026NMPA approval of novel dermatology drug for psoriasis70% success
• Q1 2027Phase 3 data readout for ophthalmology candidate targeting dry eye disease65% success
• Q3 2026In-licensing agreement for a late-stage ophthalmology asset50% success